Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Payables (2020 - 2026)

Trulieve Cannabis has reported Payables over the past 6 years, most recently at $86.7 million for Q4 2025.

  • For Q4 2025, Payables fell 58.92% year-over-year to $86.7 million; the TTM value through Dec 2025 reached $86.7 million, down 58.92%, while the annual FY2025 figure was $86.7 million, 58.92% down from the prior year.
  • Payables for Q4 2025 was $86.7 million at Trulieve Cannabis, up from $85.0 million in the prior quarter.
  • Over five years, Payables peaked at $211.1 million in Q4 2024 and troughed at $24.1 million in Q1 2022.
  • A 5-year average of $121.6 million and a median of $96.4 million in 2022 define the central range for Payables.
  • Biggest five-year swings in Payables: skyrocketed 324.25% in 2023 and later crashed 59.95% in 2025.
  • Year by year, Payables stood at $104.1 million in 2021, then soared by 83.01% to $190.6 million in 2022, then rose by 7.54% to $204.9 million in 2023, then rose by 3.02% to $211.1 million in 2024, then crashed by 58.92% to $86.7 million in 2025.
  • Business Quant data shows Payables for TCNNF at $86.7 million in Q4 2025, $85.0 million in Q3 2025, and $82.7 million in Q2 2025.